Leveraged ETF Winners Amid S&P 500's Fifth Straight Weekly Loss

Market Overview - Rising oil prices have caused significant turmoil in the global market, with the Dow Jones Industrial Average dropping 1.7%, entering correction territory, while the Nasdaq Composite declined 2.1%, deepening its correction. The S&P 500 also fell about 1.7%, marking its fifth consecutive weekly loss, the longest losing streak since 2022 [1][2]. Oil Price Impact - The recent spike in oil prices, driven by tensions in the Middle East, has led to market chaos. The outlook for oil prices is uncertain, as the duration of the disruption and the extent of damage to energy infrastructure will play crucial roles. With existing infrastructure already impacted, oil prices are unlikely to return to pre-war levels soon [2][4]. Technology Sector Performance - The "Magnificent Seven" mega-cap stocks have significantly contributed to market losses, shedding over $330 billion in market value in a single session and approximately $870 billion over the week. Shares of major tech companies have declined, with Meta particularly affected by a ruling related to social media addiction concerns [3][10]. Inflation and Interest Rates - The escalation of conflict in the Middle East and the rise in oil prices above $100 are fueling inflation fears, which may keep interest rates elevated for an extended period. This situation is particularly detrimental to growth sectors like technology [4][10]. Leveraged ETFs Performance - Several leveraged exchange-traded funds (ETFs) have performed well amidst the market downturn: - T-REX 2X Inverse CRCL Daily Target ETF (CRCD) increased by 54.4% last week, as CRCL stock slumped 24.4% [7]. - GraniteShares 2x Short COIN Daily ETF (CONI) rose by 45.2%, while Coinbase Global Inc. (COIN) shares dropped 18.7% [8]. - Tradr 2X Short IREN Daily ETF (IREZ) gained 32.5%, with IREN shares losing about 15.3% [9]. - Tradr 2X Short NBIS Daily ETF (NBIZ) increased by 30.8%, as Nebius Group (NBIS) stock slumped 13.4% [11]. - Tradr 2X Long SRPT Daily ETF (SRPU) rose by 29.0%, following positive results for Sarepta Therapeutics, Inc. (SRPT) in gene-silencing technology [12].